In R/M breast cancer, the distribution of mutations in TP53, PIK3CA, GATA3, and PTEN were similar to those in primary breast cancer (Figure 2C), indicating these gene mutations have similar roles in distinctive molecular subtypes of both primary and R/M tumors. This evidence concerns the gene GATA3 and breast carcinoma.